Corruble and colleagues claim that individuals excluded from major depressive disorder (MDD) diagnosis by the DSM Criterion E bereavement exclusion (BE) had treatment outcomes no better than other MDD patients: " [O]ur results show that the 6-week outcome of depressed patients with versus without the MDE [major depressive episode] Criterion E bereavement exclusion is not different. " 1(p5) They conclude that the BE is invalid and join those who "argue against the continued use of the bereavement exclusion criterion in DSM-5. " 1(p5) The authors' conclusions do not follow from their data. Their results show nothing about BE-excluded individuals' outcomes, because the sample generally did not qualify for exclusion. The BE does not allow exclusion if any 1 of 6 problematic conditions is present-either duration over 2 months or suicidal ideation or psychomotor retardation or morbid worthlessness, etc (see below). Table 3 in the authors' article reports the "BE" group's baseline symptoms: 70.5% psychomotor retardation, 66.8% worthlessness, and 36.0% suicidal ideation. Yet any one of these symptoms disqualifies an individual from BE exclusion. Consequently, the sample generally qualified for MDD.
The symptoms are not better accounted for by Bereavement, ie, after the loss of a loved one, the symptoms persist for longer than 2 months or are characterized by marked functional impairment, morbid preoccupation with worthlessness, suicidal ideation, psychotic symptoms, or psychomotor retardation. 4(p327) Criterion E is described as the "bereavement exclusion, " but in fact is worded as an MDD inclusion criterion. Consequently, even the common statement that an individual "satisfies the bereavement exclusion" is ambiguous-it could mean either that the individual fulfills criterion E (ie, does not have excludable bereavement, thus has MDD) or that the individual has excludable bereavement and does not qualify for MDD. To apply the BE, one must evaluate a confusing double negative. Indeed, one of us (M.B.F.) encounters the resulting confusion frequently when doing Structured Clinical Interview for DSM-IV (SCID) training sessions, with novice SCID users often coding criterion E oppositely to what they intend. The most plausible hypothesis to explain the discrepancy between the supposed BE-excluded group's symptom profile and the BE criteria is that the physicians in the Corruble et al study 1 were similarly confused.
The crucial point is that these results are not generalizable to any sample or population to which the DSM BE is correctly applied. Thus, the results have no implications for the ongoing debate about the BE's validity. At most, they indicate that the BE's current wording is confusing to novices and requires clarification.
